해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 11.22. (금)

구분	보고서(영문)
제약/바이오/임상시험 (3건)	Positive Phase II Top-Line Data Highlights Omadacycline’s Potential in the NTM Market
	Contract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share, and Outlook – 2024 Edition
	Strategic Intelligence: AI in Drug Discovery 2024
컨퍼런스/심포지엄/학회/기타 (11건)	IDWeek 2024: Strategic Approaches and Challenges in Mpox Vaccination
	AHA 2024: Plozasiran Demonstrates Promising Phase III Results in Adults with Familial Chylomicronemia Syndrome at High Risk of Acute Pancreatitis
	AHA 2024: Lerodalciep Shows Promising Results in Open-Label Extension Trial in Patients With Heterozygous Familial Hypercholesterolemia
	AHA 2024: Cardiovascular Effectiveness of GLP-1RA + Empagliflozin Combination Therapy in Adults with T2D
	AHA 2024: Semaglutide Continues to Impress in Diabetic Kidney Disease
	AHA 2024: CKD Patients Could Positively Benefit from an Aldosterone Synthase Inhibitor
	AHA 2024: GLP-1R Agonist Treatment Associated with Better Clinical Outcomes in Patients with Heart Failure and CKD
	AHA 2024: Phase III BROOKLYN Trial: Safety and Efficacy of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
	AHA 2024: Zerlasiran Shows Promising Phase II Results in Patients with Elevated Lipoprotein(a) Levels
	AHA 2024: Tirzepatide Improves Major Heart Failure Outcomes in Patients with HFpEF and Obesity in SUMMIT
	AHA 2024: Muvalaplin Demonstrates Promising Phase II Results in Patients with Elevated Serum Lipoprotein(a)
질환별 (6건)	Parkinson's Disease Clinical Research in 7MM Focuses on Disease-Modifying Agents
	Heart Failure: Seven-Market Drug Forecast and Market Analysis – Update
	Type 1 Diabetes: Epidemiology Forecast to 2033
	Neurofibromatosis: Competitive Landscape
	Hepatitis B Virus Therapeutics: Competitive Landscape
	Men’s Health Awareness Month Promotes Early Prostate Cancer Detection